Advertisement
LAB or MOBI or OFIX
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LAB’s FA Score shows that 0 FA rating(s) are green whileMOBI’s FA Score has 0 green FA rating(s), and OFIX’s FA Score reflects 1 green FA rating(s).
- LAB’s FA Score: 0 green, 5 red.
- MOBI’s FA Score: 0 green, 5 red.
- OFIX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LAB’s TA Score shows that 4 TA indicator(s) are bullish while OFIX’s TA Score has 5 bullish TA indicator(s).
- LAB’s TA Score: 4 bullish, 6 bearish.
- OFIX’s TA Score: 5 bullish, 5 bearish.
Price Growth
LAB (@Medical/Nursing Services) experienced а -8.51% price change this week, while MOBI (@Medical/Nursing Services) price change was +15.67% , and OFIX (@Medical/Nursing Services) price fluctuated +2.38% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +23.45%. For the same industry, the average monthly price growth was +12.35%, and the average quarterly price growth was -13.81%.
Reported Earning Dates
LAB is expected to report earnings on Jul 30, 2026.
MOBI is expected to report earnings on Sep 02, 2026.
OFIX is expected to report earnings on Aug 11, 2026.
Industries' Descriptions
@Medical/Nursing Services (+23.45% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| LAB | MOBI | OFIX | |
| Capitalization | 325M | 474M | 382M |
| EBITDA | -73.66M | -52.32M | 21.3M |
| Gain YTD | -35.180 | N/A | -37.665 |
| P/E Ratio | N/A | N/A | N/A |
| Revenue | 86.3M | 38.5M | 825M |
| Total Cash | 455M | 55.7M | 120M |
| Total Debt | 29.5M | 49.2M | 262M |
LAB | MOBI | OFIX | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 70 | 98 | 65 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 35 Fair valued | 57 Fair valued | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 45 | 100 | |
SMR RATING 1..100 | 56 | 100 | 96 | |
PRICE GROWTH RATING 1..100 | 82 | 50 | 82 | |
P/E GROWTH RATING 1..100 | 100 | 100 | 10 | |
SEASONALITY SCORE 1..100 | 90 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LAB's Valuation (35) in the Medical Specialties industry is in the same range as MOBI (57) in the Packaged Software industry, and is somewhat better than the same rating for OFIX (98) in the Medical Specialties industry. This means that LAB's stock grew similarly to MOBI’s and somewhat faster than OFIX’s over the last 12 months.
MOBI's Profit vs Risk Rating (45) in the Packaged Software industry is somewhat better than the same rating for LAB (100) in the Medical Specialties industry, and is somewhat better than the same rating for OFIX (100) in the Medical Specialties industry. This means that MOBI's stock grew somewhat faster than LAB’s and somewhat faster than OFIX’s over the last 12 months.
LAB's SMR Rating (56) in the Medical Specialties industry is somewhat better than the same rating for OFIX (96) in the Medical Specialties industry, and is somewhat better than the same rating for MOBI (100) in the Packaged Software industry. This means that LAB's stock grew somewhat faster than OFIX’s and somewhat faster than MOBI’s over the last 12 months.
MOBI's Price Growth Rating (50) in the Packaged Software industry is in the same range as LAB (82) in the Medical Specialties industry, and is in the same range as OFIX (82) in the Medical Specialties industry. This means that MOBI's stock grew similarly to LAB’s and similarly to OFIX’s over the last 12 months.
OFIX's P/E Growth Rating (10) in the Medical Specialties industry is significantly better than the same rating for MOBI (100) in the Packaged Software industry, and is significantly better than the same rating for LAB (100) in the Medical Specialties industry. This means that OFIX's stock grew significantly faster than MOBI’s and significantly faster than LAB’s over the last 12 months.
| LAB | OFIX | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 86% | 3 days ago 74% |
| Stochastic ODDS (%) | 3 days ago 87% | 3 days ago 66% |
| Momentum ODDS (%) | 3 days ago 85% | 3 days ago 83% |
| MACD ODDS (%) | 3 days ago 89% | 3 days ago 70% |
| TrendWeek ODDS (%) | 3 days ago 86% | 3 days ago 71% |
| TrendMonth ODDS (%) | 3 days ago 85% | 3 days ago 75% |
| Advances ODDS (%) | 23 days ago 80% | 17 days ago 71% |
| Declines ODDS (%) | 5 days ago 87% | 10 days ago 80% |
| BollingerBands ODDS (%) | 3 days ago 86% | 3 days ago 77% |
| Aroon ODDS (%) | 3 days ago 88% | 3 days ago 78% |
Advertisement
LAB and
Correlation & Price change
A.I.dvisor indicates that over the last year, LAB has been loosely correlated with RVTY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LAB jumps, then RVTY could also see price increases.
| Ticker / NAME | Correlation To LAB | 1D Price Change % | ||
|---|---|---|---|---|
| LAB | 100% | +2.42% | ||
| RVTY - LAB | 44% Loosely correlated | +2.23% | ||
| BLFS - LAB | 41% Loosely correlated | +1.80% | ||
| ILMN - LAB | 41% Loosely correlated | +1.79% | ||
| RGEN - LAB | 38% Loosely correlated | -1.15% | ||
| A - LAB | 37% Loosely correlated | +2.20% | ||
More | ||||
MOBI and
Correlation & Price change
A.I.dvisor tells us that MOBI and IART have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MOBI and IART's prices will move in lockstep.
| Ticker / NAME | Correlation To MOBI | 1D Price Change % | ||
|---|---|---|---|---|
| MOBI | 100% | -1.93% | ||
| IART - MOBI | 7% Poorly correlated | +2.21% | ||
| LAB - MOBI | 3% Poorly correlated | +2.42% | ||
| BRKR - MOBI | 1% Poorly correlated | +4.57% | ||
| IRIX - MOBI | 1% Poorly correlated | -3.42% | ||
| MASI - MOBI | -2% Poorly correlated | N/A | ||
More | ||||
OFIX and
Correlation & Price change
A.I.dvisor indicates that over the last year, OFIX has been loosely correlated with KIDS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if OFIX jumps, then KIDS could also see price increases.
| Ticker / NAME | Correlation To OFIX | 1D Price Change % | ||
|---|---|---|---|---|
| OFIX | 100% | +2.38% | ||
| KIDS - OFIX | 47% Loosely correlated | +3.85% | ||
| SNN - OFIX | 47% Loosely correlated | +0.03% | ||
| ENOV - OFIX | 46% Loosely correlated | +5.37% | ||
| MMSI - OFIX | 46% Loosely correlated | +3.03% | ||
| CSTL - OFIX | 45% Loosely correlated | +4.30% | ||
More | ||||